COVID-19 vaccine: Medicago to unveil clinical trial results on Tuesday

COVID-19 vaccine: Medicago will disclose clinical trial results Tuesday

MISE & Agrave; DAY

Quebec biopharmaceutical company Medicago will unveil the results of its clinical trials on its COVID-19 vaccine on Tuesday, TVA has learned.

The information that will be transmitted by the laboratory should be “very significant”, according to pharmacist Diane Lamarre.

& nbsp; “We remember that the laboratory developed a plant-based vaccine,” says Ms. Lamarre.

& nbsp; The company had hoped to submit an application for approval of its vaccine to Health Canada earlier this fall, but has experienced delays especially due to difficulties in recruiting candidates for clinical trials.

& nbsp; In October 2020, the Government of Canada reached an agreement with Medicago for the purchase of 20 million doses of COVID-19 vaccines, with the option of obtaining them An additional 56 million.

& nbsp; These 20 million doses would be produced at the Quebec pilot plant as well as at this North Carolina Island.

Share Button